金币
UID176556
帖子
主题
积分25187
注册时间2014-6-6
最后登录1970-1-1
听众
性别保密
|
发表于 2017-9-3 21:20:33
|
显示全部楼层
LD50是和动物以及给药途径相关的,首先你得至少确认这些LD50是否和下一个品种的给药途径相同,以及这些LD50是基于相同的动物模型的出来的,否则比较没有意义。
另一方面下文选自PDA TR29,仅供参考!
10.12 Excipients
The excipients used for a drug product should be considered in the cleaning validation program. One
issue for excipients is the possible effect on cleaning of a drug product. This effect is generally more
pronounced for solid dosage products, where the excipient may be a coating or other functional mate-
rial designed to retard dissolution. This is one reason why some companies prefer to use a laboratory
cleaning study, as compared to only evaluating the solubility of the active ingredient, to determine the
difficulty of cleaning of different products in a grouping approach.
Unless the excipient has some kind of unusual toxicity, limits are generally not set for excipients in
a cleaning validation protocol. A case where limits may be set for excipients is where the excipient
is known to have a significant effect on the performance of the next manufactured product, such as
complexing with the API to reduce bioavailability. However, it should be recognized that in all cases,
residues of excipients after cleaning should be such that the equipment is visually clean. A surface
which is not “visually clean” due to a high level of an excipient should be generally considered a clean-
ing validation failure.
|
|